immunotherapy

• 

Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer

By Sharon Deveson Kell|2022-03-25T09:17:25+00:0025 Mar 2022|Drug treatments|

Researchers are interested in the bacteria in our gut (the [...]

Read More

Comments Off on Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer

• 

Diagnosis and treatment of collecting duct carcinoma of the kidney

By Sharon Deveson Kell|2022-03-15T08:22:06+00:0015 Mar 2022|Drug treatments|

Collecting duct carcinoma of the kidney is a very aggressive [...]

Read More

Comments Off on Diagnosis and treatment of collecting duct carcinoma of the kidney

• 

Immunotherapy after progression of metastatic kidney cancer

By Sharon Deveson Kell|2022-03-04T08:50:07+00:004 Mar 2022|Drug treatments|

Vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKI) are [...]

Read More

Comments Off on Immunotherapy after progression of metastatic kidney cancer

• 

ASCO GU 2022: Choosing between combination treatments for advanced kidney cancer

By Sharon Deveson Kell|2022-02-24T08:58:17+00:0024 Feb 2022|Drug treatments|

Combination therapies have revolutionised the first-line treatment of metastatic clear [...]

Read More

Comments Off on ASCO GU 2022: Choosing between combination treatments for advanced kidney cancer

• 

ASCO GU 2022: Treatment of sarcomatoid kidney cancer with immunotherapy

By Sharon Deveson Kell|2022-02-24T08:50:34+00:0024 Feb 2022|Drug treatments|

Metastatic sarcomatoid clear cell RCC is an aggressive type of [...]

Read More

Comments Off on ASCO GU 2022: Treatment of sarcomatoid kidney cancer with immunotherapy

• 

ASCO GU 2022: Cytoreductive nephrectomy for patients with lung metastases

By Sharon Deveson Kell|2022-02-24T08:40:22+00:0024 Feb 2022|Surgery|

Cytoreductive nephrectomy is the surgical removal of the tumour to [...]

Read More

Comments Off on ASCO GU 2022: Cytoreductive nephrectomy for patients with lung metastases

• 

ASCO GU 2022: Cytoreductive nephrectomy for patients with tumour thrombus

By Sharon Deveson Kell|2022-02-24T08:35:36+00:0024 Feb 2022|Surgery|

Cytoreductive nephrectomy is the surgical removal of the tumour to reduce the number [...]

Read More

Comments Off on ASCO GU 2022: Cytoreductive nephrectomy for patients with tumour thrombus

• 

Stereotactic radiotherapy and pembrolizumab for kidney cancer

By Sharon Deveson Kell|2022-02-14T09:15:23+00:0014 Feb 2022|Drug treatments|

Results from the phase 1/2 RAPPORT trial show that stereotactic [...]

Read More

Comments Off on Stereotactic radiotherapy and pembrolizumab for kidney cancer

• 

Outcomes of patients who stopped immunotherapy due to immune-related side effects

By Sharon Deveson Kell|2022-02-09T14:47:05+00:009 Feb 2022|Drug treatments|

Immunotherapy has changed the way advanced renal cell carcinoma (RCC) [...]

Read More

Comments Off on Outcomes of patients who stopped immunotherapy due to immune-related side effects

• 

Immunotherapy combinations in the first-line treatment of metastatic sarcomatoid kidney cancer

By Sharon Deveson Kell|2021-11-10T09:25:50+00:0010 Nov 2021|Drug treatments|

A recent study looked at the efficacy and safety of [...]

Read More

Comments Off on Immunotherapy combinations in the first-line treatment of metastatic sarcomatoid kidney cancer